Eugene Myron Holuka
Director · CITIUS ONCOLOGY, INC.
Individual
- 2024
- Dec 22, 2025
- 5
Other insiders active in the same sector
No other insider has filed at Eugene Myron Holuka's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Bain Capital Life Sciences Investors, LLC - $115.00M in HTFL purchases and sales in the last 12 months
- Michael Simanovsky - $110.65M in SNDA purchases and sales in the last 12 months
- Mayukh Sukhatme - $109.13M in ROIV purchases and sales in the last 12 months
- Emily M. Leproust - $101.55M in TWST purchases and sales in the last 12 months
- Bruce Booth - $100.59M in KYMR purchases and sales in the last 12 months
- Paul A. Mahon - $98.96M in UTHR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Eugene Myron Holuka?
Eugene Myron Holuka is a corporate insider, tracked as Director of CITIUS ONCOLOGY, INC. (CTOR). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Eugene Myron Holuka last file a Form 4?
The most recent primary Form 4 on record is dated 22 December 2025, one of 5 filings going back to 2024.
